Filtered By:
Management: Centers for Disease Control and Prevention (CDC)
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 231 results found since Jan 2013.
Why You Should Rest —a Lot—If You Have COVID-19
Until recently, running was a major part of Emma Zimmerman’s life. The 26-year-old freelance journalist and graduate student was a competitive distance runner in college and, even after she graduated, logged about 50 miles per week. So she tentatively tried to return to her running routine roughly a week after a probable case of COVID-19 in March, doing her best to overcome the malaise that followed her initial allergy-like symptoms. Each time, though, “I’d be stuck in bed for days with a severe level of crippling fatigue,” Zimmerman says.
Months later, Zimmerman still experiences health issues incl...
Source: TIME: Health - September 23, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Anthony Fauci, loved and hated, plots his next move: ‘I'm not going to sit in my house’
In 1984, when Anthony Fauci took over as head of the National Institute of Allergy and Infectious Diseases (NIAID), his wife gave him a plant for the new office. Both the palm and the 81-year-old physician are still there, the giant plant now crowding the office of one of the most celebrated—and polarizing—scientific figures in U.S. history. But not for much longer. Fauci announced on 22 August that he would step down at the end of the year from both NIAID and his post as the chief medical adviser to President Joe Biden.
“What am I going to do with this plant? It’s a monster. I can’t fit it in any other plac...
Source: ScienceNOW - September 1, 2022 Category: Science Source Type: news
Anthony Fauci, loved and hated, plots his next move: ‘I’m not going to sit in my house’
In 1984, when Anthony Fauci took over as head of the National Institute of Allergy and Infectious Diseases (NIAID), his wife gave him a plant for the new office. Both the palm and the 81-year-old physician are still there, the giant plant now crowding the office of one of the most celebrated—and polarizing—scientific figures in U.S. history. But not for much longer. Fauci announced on 22 August that he would step down at the end of the year from both NIAID and his post as the chief medical adviser to President Joe Biden.
“What am I going to do with this plant? It’s a monster. I can’t fit it in any other plac...
Source: ScienceNOW - September 1, 2022 Category: Science Source Type: news
Your Kid ’ s School Needs Better Ventilation to Help Keep COVID-19 in Check
Across the country, K-12 schools are starting their next year of classes in the middle of a COVID-19 surge. As the BA.5 Omicron subvariant drives thousands of reinfections, schools have largely put aside safety measures like mask requirements and physical distancing.
In response, some parents and experts are trying to improve ventilation in schools, since better air quality in buildings can reduce COVID-19’s spread and even improve other health outcomes. But, despite readily available resources—including millions of dollars in funding from the federal government—many schools have not invested in upgrading...
Source: TIME: Health - August 16, 2022 Category: Consumer Health News Authors: Betsy Ladyzhets Tags: Uncategorized biztech2030 COVID-19 healthscienceclimate Source Type: news
What to Know About the Monkeypox Drug TPOXX —And Why It ’ s So Hard to Get
Monkeypox, which federal officials declared a public health emergency on August 4, is not as contagious as the other ongoing public health emergency in the U.S.: COVID-19. Monkeypox primarily spreads through contact with infected skin lesions. Theoretically, containing monkeypox should therefore be more feasible, as long as testing, vaccines, and treatments are accessible. But in reality, the rollouts of all three approaches have faced major challenges. Getting the antiviral drug tecovirimat, also known as TPOXX, is particularly difficult.
Here’s what to know about the antiviral drug treatment TPOXX.
What is TPOXX?
T...
Source: TIME: Health - August 9, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate monkeypox Source Type: news
Why You Shouldn ’t Wait for Updated COVID-19 Boosters
A new version of Omicron, BA.5, is now responsible for more than half of new infections in the U.S. No one seems safe from being able to catch it: not even vaccinated people or those who have gotten COVID-19 in the past. That’s because this virus is different enough from the original version—and even from previous versions of Omicron—that the vaccines and booster shots everyone has been getting are less effective against BA.5. Plus, any immunity that people generate, whether after getting vaccinated or infected naturally, wanes after several months.
Given the nation’s diminished immunity and current...
Source: TIME: Health - July 13, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Why You Shouldn ’ t Wait for Updated COVID-19 Boosters
A new version of Omicron, BA.5, is now responsible for more than half of new infections in the U.S. No one seems safe from being able to catch it: not even vaccinated people or those who have gotten COVID-19 in the past. That’s because this virus is different enough from the original version—and even from previous versions of Omicron—that the vaccines and booster shots everyone has been getting are less effective against BA.5. Plus, any immunity that people generate, whether after getting vaccinated or infected naturally, wanes after several months.
Given the nation’s diminished immunity and current...
Source: TIME: Health - July 13, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
New head of U.S. aid program for HIV/AIDS vows to refocus attention on the other, ‘silent’ pandemic
On 13 June, John Nkengasong, 58, was appointed the first African-born head of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), a program that helps more than 50 countries respond to their HIV/AIDS epidemics. Nkengasong, who grew up in Cameroon and became a U.S. citizen in 2007, previously ran the Africa Centres for Disease Control and Prevention (Africa CDC).
PEPFAR is credited with helping save more than 20 million lives since its inception in 2003. It had a $10.7 billion budget in 2021, more than half of it spent on HIV treatment and care. The agency has relied on an acting director since Deborah Birx...
Source: Science of Aging Knowledge Environment - July 5, 2022 Category: Geriatrics Source Type: research
There ’s a shortage of monkeypox vaccine. Could one dose instead of two suffice?
As the monkeypox outbreak grows, the preferred vaccine to combat it is in short supply—a problem that’s only getting worse now that countries are expanding access to the vaccine. But there is a strategy that could double overnight the number of people who can be vaccinated: use a single shot instead of the recommended two.
Compelling data from monkey and human studies suggest a single dose of the vaccine—produced by Bavarian Nordic and sold under three different brand names—solidly protects against monkeypox, and that the second dose mainly serves to extend the durability of protection.
The United Kingdom...
Source: Science of Aging Knowledge Environment - July 1, 2022 Category: Geriatrics Source Type: research
What to Know About the Latest Advances in Managing Severe Asthma
Graphs and charts don’t always tell the whole story. Numbers can be deceiving. But anyone who looks at U.S. trends in asthma mortality can see, without squinting, that things are moving in the right direction.
A 2019 analysis in the American Journal of Respiratory and Critical Care Medicine found that from 1999 to 2015, asthma mortality fell by 43%. “The decrease in asthma-related mortality was consistent in both sexes and in all race groups, with the largest decrease in patients older than 65 years,” the authors concluded. Figures from the U.S. Centers for Disease Control and Prevention indicate that the...
Source: TIME: Health - June 23, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news
News at a glance: China ’s carbon pledge, ARPA-H’s interim head, and an exascale computer
Some content has been removed for formatting reasons. Please view the original article for the best reading experience.
Table of contents
A version of this story appeared in Science, Vol 376, Issue 6597.
Download PDF
CONSERVATION
U.S. moves to stop Alaska copper mine
The U.S. Environmental Protection Agency (EPA) is moving to block construction of a massive copper and gold mine that would risk polluting the headwaters of Alaska’s Bristol Bay, home to the world’s largest sockeye salmon runs. EPA announced last week it plans to forbid dis...
Source: Science of Aging Knowledge Environment - June 2, 2022 Category: Geriatrics Source Type: research
Outcomes of allergic-type reactions after messenger RNA coronavirus disease 2019 vaccination at 3 military medical centers
In response to the global coronavirus disease 2019 (COVID-19) pandemic, 2 messenger RNA (mRNA) COVID-19 vaccines were developed and authorized for use.1,2 Adverse events following immunization (AEFI) have occurred after receipt of these vaccines to include anaphylaxis that is estimated to occur at a rate of 2.5 to 11 cases per 1 million doses.3 Several studies have found tolerance to vaccine challenge in these individuals, suggesting the reactions are likely not immunoglobulin (Ig)E driven.4,5 The Centers for Disease Control and Prevention now considers nonsevere, immediate, allergic-type reactions after a dose of a COVID-...
Source: Annals of Allergy, Asthma and Immunology - May 19, 2022 Category: Allergy & Immunology Authors: Benjamin D. St. Clair, Donna L. Hoffman, Bruce McClenathan, Taylor Banks, Rachel U. Lee Tags: Letters Source Type: research
Outcomes of Allergic Type Reactions Following mRNA COVID-19 Vaccination at Three Military Medical Centers
In response to the global COVID-19 pandemic two mRNA COVID-19 vaccines were developed and authorized for use1,2. Adverse events following immunization (AEFI) have occurred following receipt of these vaccines to include anaphylaxis that is estimated to occur at a rate of 2.5 to 11 cases per 1 million doses3. Several studies have demonstrated tolerance to vaccine challenge in these individuals, suggesting the reactions are likely not IgE driven4,5. The Centers for Disease Control and Prevention now considers non-severe, immediate allergic-type reactions following a dose of a COVID-19 vaccine a precaution, not a contraindicat...
Source: Annals of Allergy, Asthma and Immunology - May 19, 2022 Category: Allergy & Immunology Authors: Benjamin D. St Clair, Donna L. Hoffman, Bruce McClenathan, Taylor Banks, Rachel U. Lee Tags: Letters Source Type: research
Tim Kaine Refuses to Let Long COVID Be an Afterthought
When Virginia Sen. Tim Kaine came down with a “blizzard” of allergy-like symptoms in March 2020, he blamed the layer of pollen coating his car. “It was Washington, D.C., in late March,” he says. I thought, “‘Okay, well, this is hay fever gone wild.’”
Only when his wife, Anne Holton, developed “textbook” COVID-19 symptoms did Kaine start to wonder if he might have the new virus, the subject of the massive economic assistance bill—the CARES Act—that he and other lawmakers were then working to pass. Testing at that time was hard to come by, even for Hill...
Source: TIME: Health - May 4, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 feature Source Type: news
Mayo Clinic Minute: How to manage hay fever allergy symptoms
Don't be alarmed if you are experiencing seasonal allergies for the first time. While hay fever — also known as allergic rhinitis — often begins in childhood, more adults are being diagnosed, according to the Centers for Disease Control and Prevention. Dr. Jay-Sheree Allen, a Mayo Clinic family medicine physician, says seasonal allergies can make you feel miserable. It's your body's way of fighting off a perceived threat.Watch: The Mayo Clinic Minute. https://www.youtube.com/watch?v=1zfs6wlIEO4 Journalists: Broadcast-quality…
Source: News from Mayo Clinic - May 4, 2022 Category: Databases & Libraries Source Type: news
